Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease

Abstract This evidence-based clinical practice guideline for the prevention, diagnosis, and treatment of Lyme disease was developed by a multidisciplinary panel representing the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheuma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 2021-01, Vol.72 (1), p.e1-e48
Hauptverfasser: Lantos, Paul M, Rumbaugh, Jeffrey, Bockenstedt, Linda K, Falck-Ytter, Yngve T, Aguero-Rosenfeld, Maria E, Auwaerter, Paul G, Baldwin, Kelly, Bannuru, Raveendhara R, Belani, Kiran K, Bowie, William R, Branda, John A, Clifford, David B, DiMario, Francis J, Halperin, John J, Krause, Peter J, Lavergne, Valery, Liang, Matthew H, Meissner, H Cody, Nigrovic, Lise E, Nocton, James (Jay) J, Osani, Mikala C, Pruitt, Amy A, Rips, Jane, Rosenfeld, Lynda E, Savoy, Margot L, Sood, Sunil K, Steere, Allen C, Strle, Franc, Sundel, Robert, Tsao, Jean, Vaysbrot, Elizaveta E, Wormser, Gary P, Zemel, Lawrence S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract This evidence-based clinical practice guideline for the prevention, diagnosis, and treatment of Lyme disease was developed by a multidisciplinary panel representing the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR). The scope of this guideline includes prevention of Lyme disease, and the diagnosis and treatment of Lyme disease presenting as erythema migrans, Lyme disease complicated by neurologic, cardiac, and rheumatologic manifestations, Eurasian manifestations of Lyme disease, and Lyme disease complicated by coinfection with other tick-borne pathogens. This guideline does not include comprehensive recommendations for babesiosis and tick-borne rickettsial infections, which are published in separate guidelines. The target audience for this guideline includes primary care physicians and specialists caring for this condition such as infectious diseases specialists, emergency physicians, internists, pediatricians, family physicians, neurologists, rheumatologists, cardiologists and dermatologists in North America.
ISSN:1058-4838
1537-6591
DOI:10.1093/cid/ciaa1215